TuisCATX • NYSEAMERICAN
add
Perspective Therapeutics Inc
Vorige sluiting
$3,12
Dagwisseling
$3,16 - $3,57
Jaarwisseling
$1,60 - $16,55
Markkapitalisasie
246,44 m USD
Gemiddelde volume
1,06 m
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 342,00 k | 5,23% |
Bedryfskoste | 8,74 m | 42,31% |
Netto inkomste | -18,18 m | -47,97% |
Netto winsgrens | -5,31 k | -40,62% |
Wins per aandeel | -0,25 | — |
EBITDA | -21,10 m | -66,81% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 211,70 m | 17,19% |
Totale bates | 329,35 m | 18,35% |
Totale aanspreeklikheid | 44,70 m | -7,63% |
Totale ekwiteit | 284,64 m | — |
Uitstaande aandele | 74,23 m | — |
Prys om te bespreek | 0,81 | — |
Opbrengs op bates | -16,28% | — |
Opbrengs op kapitaal | -18,72% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -18,18 m | -47,97% |
Kontant van bedrywe | -21,58 m | -255,85% |
Kontant van beleggings | -5,56 m | 88,23% |
Kontant van finansiering | 9,97 m | -94,00% |
Netto kontantverandering | -17,17 m | -112,92% |
Beskikbare kontantvloei | -20,92 m | -19,98% |
Meer oor
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
Gestig
2004
Hoofkwartier
Webwerf
Werknemers
138
